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CASE STUDY: VOICE OF TOBACCO VICTIMS SUCCESS WITH INDIAN DENTAL
ASSOCIATION
Kunal Oswal 1, Ashima Sarin 1, Pankaj Chaturvedi 2. 1Healis-Sekhsaria Institute
for Public Health, India; 2Tata Memorial Hospital, India
Background: Voice of Tobacco Victims (VoTV) is a campaign lead by patients and
their families who share their heart wrenching stories with the policy makers.
The doctor who has treated the patient is also part of the platform, one to
reassure the victim and second to provide clinical support for the statement
made by the victims. In the VoTV, doctors are often referred as patrons. The
victims not only present their story and the impact tobacco had on their lives,
they also advocate for adoption of and implementation of effective tobacco
control policy. To curb this menace it is necessary to mobilise the key stake-
holder so as to have strong lobby while doing advocacy with policy makers or
key stakeholders.
Objective: The objectives were to involve the professional body like Indian
Dental Association to be a part of the campaign and make its presence felt.
Method: VoTV networked and got associated with the Indian Dental Association.
The professional association are representatives nationally with branches at
state and local level all over India. Liaising with such body proved to be vital
to garner support for lobbying with policy makers for effective tobacco control
at local, state and national level
Result: Indian Dental association of Uttarpradesh and Assam filed a Public
Interest Litigation for the Gutka Ban in the respective state. Furthermore it
also became party in the Ankur Gutka case. IDA through its state branch partic-
ipated in the VoTV chapter of Bihar. IDA at national level launched a campaign
addressing the prime minister to ban packaged and flavoured smokeless tobacco
product. In Maharashtra, results shared with the high court on the prevalence
of oral submucous fibrosis were taken into account while fighting for gutka and
pan masala ban.
Conclusion: Involving key stakeholders like dentist through IDA is vital for ad-
vocacy campaign. The professional body represent the society and their voice
put a lot of pressure on policy makers where there is lax in implementation of
policy
Beyond cigarettes: smokeless tobacco, ENDS (electronic
nicotine delivery system)
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PERCEPTIONS OF TEXT AND PICTORIAL HEALTH WARNINGS FOR SMOKELESS
TOBACCO IN INDIA AND BANGLADESH
Prakash C. Gupta 1, Seema Mutti 2, Nigar Nargis 3, Jessica L. Reid4,
Hemlata Shedge1, David Hammond2. 1Healis-Sekhsaria Institute for Public
Health, India; 2University of Waterloo, Canada; 3University of Dhaka,
Bangladesh; 4Propel Centre for Population Health Impact, Canada
Background: India and Bangladesh have more smokeless tobacco (SLT) users
than the rest of the world combined. Health warnings on packages are among
the most cost-effective means to communicate the health effects of tobacco
use, which remains a priority for tobacco control policy. India was the first
country in the world to implement pictorial warnings for SLT packages; no
warnings are required on products in Bangladesh. There is little evidence on
the efficacy of warnings in India, and very limited research in general to guide
regulators in low and middle-income countries on selecting content.
Objective: This study sought to 1) develop the evidence base for more effective
health warnings for SLT packages in India and Bangladesh, and 2) assess patterns
of use and perceptions of risk about SLT.
Method: An experimental study was conducted in India (n=1,002) and
Bangladesh (n=1,081), with adult SLT users, and youth users and non-users.
Respondents were randomly assigned to view 5 SLT health warnings for 5 differ-
ent health effects according to one of four experimental conditions: 1) text-only
warning, 2) pictorial warning with symbolic imagery, 3) pictorial warning with
a graphic health effect, or 4) pictorial warning with a personal testimonial.
Result: Awareness of health warnings on packs was higher in India than in
Bangladesh. A majority (89%) of adult and youth SLT users in India and
Bangladesh reported daily use. SLT users in India reported greater quit in-
tentions than users in Bangladesh (p<0.001). Respondents were more likely
to report “less harm” (54%) as the primary reason for selecting their “usual
product”. Indian respondents were more likely to believe that SLT was more
harmful than cigarettes (66.5%) or bidis (70.2%), compared to Bangladeshi re-
spondents (50.0%, p<0.001; 50.4%, p<0.001). Text-only warnings were rated as
less effective than all of the pictorial warnings (p<0.001 for all). Among picto-
rial warnings, graphic health effects were rated as most effective, followed by
personal testimonials, and symbolic imagery (p<0.001 for all contrasts). More
than three-quarters of respondents in India reported that SLT packs should have
more health information, and 80% in Bangladesh believe that packs should have
health warnings.
Conclusion: False health beliefs about smokeless tobacco are common in India
and Bangladesh. There is strong evidence for the efficacy of graphic pictorial
health warnings and strong support among users for their implementation.
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THE RISE OF E-CIGARETTES: AN EMERGING THREAT TO THE TOBACCO
ENDGAME?
Angela Pratt 1, Laura Su2, Carmen Audera-Lopez2, James Rarick2,
Susy Mercado2. 1WHO China Office, Beijing, Chine; 2WHO, Western Pacific
Region Office, Manila, Philippines
Background: Electronic cigarettes (e-cigarettes) first developed in China in
2004are gaining popularity and the number of e-cigarette users is growing
rapidly. E-cigarette manufacturers and supporters of the devices argue that
e-cigarettes are a safe alternative to tobacco smoking, and that they may aid
smoking cessation. However, there is currently insufficient scientific evidence
to prove their safety and efficacy. Furthermore, at the 5th session of the WHO
FCTC Conference of Parties, concerns were raised that ENDs have been aggres-
sively advertised and marketed as imitation or substitute tobacco products and
as cessation devices around the world. Parties called for WHO to gather more
evidence on whether e-cigarettes are safe, their efficacy as cessation aids, and
that they don' t act as a gateway to nicotine addiction for young people.
Objectives: The objective of this paper is to discuss health concerns on e-
cigarettes and to provide an overview of recent responses and regulations
made by governments to ensure protection from potential health threats to
individuals and populations. It will also examine the different marketing strate-
gies employed by manufacturers in order to highlight the need for regulation
of these products.
Methodology: Systematic review of existing online information.
Results: This paper consolidates existing information and evidence and outlines
priorities for research and policy development.
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THROUGH THE SMOKE-SCREEN: EMPOWERING YOUTH TO SPEAK AGAINST
SHISHA SMOKING
Vasuki Utravathy, Aurelia Ong, Vijayalakshimi Karupiah. Health Promotion
Board, Singapore
Background: The first shisha outfit was set up in 2001 and in a decade, there
are about 43 outlets all around Singapore. Shisha has a disproportionate traction
among Singapore residents, especially among those aged 18–39 years. IT is also
rising in popularity among non-cigarette smoking youth.
Objective: The disproportionate use and favourable view of shisha among the
youths and young adults is of concern as international studies have shown that
shisha smoking is a potential gateway drug for youth, who will progress to
cigarette smoking in future and even become dual user (i.e. regular users of
shisha and cigarettes).
Method: In March 2012, HPB strengthened its public education measures with
its first-ever targeted public education campaign reaching out to the patrons
of the shisha café to increase awareness on the health risks associated with
shisha smoking. Measures adopted included a geo-targeted MMS clip as well
as presence of youth advocates engaging peers in discussions on ill-effects of
shisha smoking.
Result: Three weeks post-campaign, 214 respondents (including 88 shisha smok-
ers) were interviewed on the effectiveness of the campaign in raising awareness
on the harms of shisha smoking. 87% of the respondents recalled the key mes-
sage of the campaign correctly and 60% of non-shisha smokers mentioned that
they would refuse to smoke shisha in the future. 20% of them also mentioned
that they will inform their friends and family who smoke shisha about the harms
of the product and discourage them from doing so.
Conclusion: Creative campaigns and engagement of trained peer advocates
can have the unintended consequence of disseminating, especially in this age
of social media.
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SELF-REPORTED TOBACCO USE AND 24-HOUR URINARY COTININE LEVELS IN
RURAL GOA
Preet Kaur Dhillon1, Ruby Gupta 1, Dilip Jha 1, Amit Dias 2, Vikram Patel 2,
Sherin Abraham2, Shah Ebrahim1. 1South Asia Network for Chronic Disease,
PHFI, New Delhi, India; 2Sangath, Goa, India
Background: In India, tobacco is consumed in various forms, and in recent
years, smokeless tobacco has become more common than cigarette or beedi
smoking (Rani M et al, 2003, Dhawan P et al, 2009). Cotinine, a stable metabo-
lite of nicotine, is considered the best biomarker of tobacco consumption and
can be measured from saliva, blood or urine samples.
Objective: As part of a community-based study on chronic diseases and risk
factors in rural Goa, we assessed 24-hour urinary cotinine levels to validate
self-reported tobacco habits in a group of 98 men and women classified as non-
users (20%), cigarette smokers (24.2%), passive smokers (15.8%) and tobacco
chewers (40%).
Method: Demographic, lifestyle, risk factor and anthropometric data were col-
lected via interviewer-administered standardized questionnaires. 24-hour urine
samples were collected starting after the first morning' s void, stored in steril-
ized, two-liter containers at –200°C, and transported to the SANCD, PHFI/CCDC
Genetics and Biochemistry Laboratory, New Delhi for analysis. Cotinine was
estimated using kits from Calbiotech Inc, CA 91978.
